It's Time For-Jdrf-Gulfport-Curing Type 1 Diabetes
Appreciate us at http://helpkidsdonate.jdrftypeone.com
Living with T1D is a constant balancing act. People with T1D must regularly monitor their blood-sugar level, inject or continually infuse insulin through a pump, and carefully balance their insulin doses with eating and daily activities throughout the day and night.
T1D is a serious and stressful disease to manage. Treatment options are improving all the time, and people with T1D are able to lead normal, productive and inspiring lives. JDRF is driving research to improve the technology people with T1D use to monitor blood-sugar levels and deliver the proper doses of insulin, as well as research that will ultimately deliver a cure. But even with intensive disease management, a significant portion of their day is still spent with high or low blood-sugar levels, placing people with T1D at risk for devastating complications such as heart attack, stroke, blindness, kidney disease and amputation. Gulfport is the second-largest city is Mississippi, and touts a prime Gulf Coast location. The city attracts residents with its affordable cost of living, but it’s likewise an attractive vacation destination, particularly for families. While the city was hard hit by Hurricane Katrina in 2005, aggressive clean-up has resulted in a bolstered tourism industry, as travelers once again flock to the Gulf region. Situated on nearly seven miles of white sandy beaches, Gulfport offers fun things to do onshore and off. The subtropical climate allows for outdoor activities year-round, and the unspoiled environment gives nature lovers and sports enthusiasts plenty to explore. The Health Care and Social Assistance industry includes establishments and services such as:
hospitals, nursing and residential care facilities and out-patient care centres; offices of health practitioners (i.e. dentists, doctors, optometrists and chiropractors); medical and diagnostic laboratories; home health care services; ambulance services; social assistance services (i.e. for children, youth, the elderly, families); community food, housing, emergency and relief services; vocational rehabilitation services; and daycare services Video Credits can be found here http://broadcaster.beazil.net/public/credits/youtube/videos/44714 JDRF is the only organization with a strategic research plan to end T1D. Our strategies include: Artificial Pancreas Systems Artificial pancreas systems will eliminate blood glucose testing and carb counting by totally automating insulin dosing, initially preventing dangerous low blood sugars and eventually ensuring ideal glucose control. Complications JDRF’s complications research is leading to therapies to treat and even reverse some of the debilitating, costly, and life-threatening complications caused by T1D. Encapsulation JDRF’s encapsulation research will restore insulin independence for 18 months to two years
by implanting newly created beta cells into a protective capsule, which eliminates the need for toxic immune suppression therapies. JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF has led the search for a cure for T1D since our founding in 1970. In those days, people commonly called the disease “juvenile diabetes” because it was frequently diagnosed in, and strongly associated with, young children. Our organization began as the Juvenile Diabetes Foundation. Later, to emphasize exactly how we planned to end the disease, we added a word and became the Juvenile Diabetes Research Foundation.Today, we know an equal number of children and adults are diagnosed every day—approximately 110 people per day.
Welcome to our blog http://jdrf.org/blog/
Become our followers at https://plus.google.com/110620633690555176280/
Check our YouTube channel https://www.youtube.com/user/jdrfonline
Get familiar with us at our Facebook account https://www.facebook.com/myJDRF
Subscribe to our Twitter account https://twitter.com/JDRFTypeOne
See more at https://www.linkedin.com/company/jdrf
See more at https://www.instagram.com/jdrfadvocacy/
Get familiar with our Pinterest account https://www.pinterest.com/jdrfadvocacy/
The main points are –
diabetes related complications,heart attack,Intermediate Acting Insulin,insulin receptors,Set Sail Away-Day Cruises,support,noninsulin monotherapy,IFG,b-cell destruction,NovoLog,Glucose,(DCCT),Novolin R,Juvenile Diabetes Research Foundation,insulin adjustment,JDRFCC,glyburide,glucose,insulin therapy,Translating Research Into Action for Diabetes Study,ketonuria,Sodium–glucose cotransporter 2 inhibitors,transplantation insulin-secreting cells,Severe hypoglycemia,Countdown,Type 1,Jump to cure Diabetes,assessment of glycemic control,juvenile-onset diabetes,Clinical Trial,noninsulin treated patients,hypoglycemia unawareness,diabetes diagnosis,antihyperglycemic.